Henrietta Lacks was born Loretta Pleasant in Roanoke, Virginia, in 1920 and grew up in the tobacco country of Clover, Virginia. She was part of a Black rural world shaped by family labor, migration, poverty, church, kinship, and the long shadow of slavery. Her story is often introduced at the laboratory door, but it began far from that door, with a young woman whose life included children, work, cousins, illness, laughter, and the ordinary demands of survival.

In 1951, Lacks went to Johns Hopkins Hospital in Baltimore for treatment of cervical cancer. Johns Hopkins was one of the few major hospitals in the area that treated Black patients, but care was segregated and medical authority was not evenly shared. During her treatment, doctors removed samples of her tumor. Johns Hopkins and NIH accounts agree on the central ethical fact: the specimens were obtained without her knowledge or consent.

The cells were sent to the laboratory of George Gey, who had been trying to grow human cells outside the body. Most samples died quickly. Lacks's cancer cells did not. They divided again and again, doubling rapidly and surviving in ways researchers had not seen before. The cell line was named HeLa from the first letters of her first and last names.

That breakthrough changed biomedical research. HeLa cells could be shared, shipped, standardized, and used in experiments that would have been impossible or much slower with fragile cell samples. They were used in polio vaccine testing, cancer research, virology, radiation studies, toxicology, genetics, reproductive medicine, and later research tied to HIV and other diseases. NIH's HeLa site notes more than 110,000 publications citing HeLa use between 1953 and 2018. The point is not that every modern advance came from one cell line. The point is that HeLa became a platform on which huge portions of modern biomedical science learned to stand.

Henrietta Lacks did not live to see any of that. She died on October 4, 1951, at age 31. Her children lost their mother. Her husband lost his wife. The scientific world gained a tool it quickly treated as detached from the woman who made it possible.

For years, the family was not told clearly what had happened. When researchers later contacted relatives for blood samples, the family began to understand that Lacks's cells were alive in laboratories around the world. That discovery was not simple pride. It was confusion, grief, anger, and violation. Some family members struggled to get health care while companies sold HeLa-related products and researchers built careers from the cell line. Medical records and genetic information were discussed publicly in ways the family had not meaningfully controlled.

The law and ethics of tissue research in 1951 were different from today's informed-consent standards, but that cannot become an excuse. Ethics is not only what a regulation required at the time. It is also about power: who was asked, who was told, who was believed, who could refuse, and whose privacy counted. Black patients had reason to distrust medical institutions because those institutions had repeatedly treated Black bodies as teaching material, research material, or clinical opportunity without equal regard for personhood.

In 2013, the publication of HeLa genome data created a new privacy crisis. Because HeLa came from Henrietta Lacks, the genome data could also reveal information about her descendants. NIH worked with members of the Lacks family to create a controlled-access process for HeLa whole-genome sequence data. The agreement included Lacks family representation in review of access requests. It was not full ownership, and it did not compensate the family for decades of use. But it marked a public acknowledgment that the family had a legitimate stake in a scientific legacy created from their mother and grandmother's body.

Henrietta Lacks matters because her story refuses separation. It is science and family. Discovery and exploitation. Public benefit and private harm. Progress and consent. The cells are extraordinary, but the education begins when readers understand that "HeLa" was never just a lab label. It was Henrietta Lacks, a Black woman who went to the hospital for care and became part of medical history without being asked.